Filing Details
- Accession Number:
- 0001140361-11-051506
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-02 18:31:15
- Reporting Period:
- 2011-11-01
- Filing Date:
- 2011-11-02
- Accepted Time:
- 2011-11-02 18:31:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380710 | Eric George Davis | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-10-31 | 260 | $13.23 | 39,911 | No | 5 | A | Direct | |
| Common Stock | Disposition | 2011-11-01 | 260 | $33.23 | 39,651 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 29, 2011 to October 31, 2011.
- Transaction made pursuant to a Rule 10b5-1 Trading Plan, executed March 14, 2011.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $32.94 to $33.725. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Billionaire Hedge Funds
